FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, C.F.R. 820.70(i) How To Avoid FDA Warning Letters FDA issued a warning letter to a medical spa for failing to follow requirements that help ensure prescription drugs are safe and come from verified sources. These safeguards protect patients from potentially